4766
M. V. Reddy et al. / Tetrahedron Letters 52 (2011) 4764–4767
(dd, J = 10.8, 2.2 Hz, 2H), 6.76 (d, J = 8.2 Hz, 2H), 6.68 (d,
Experimental section
J = 8.0 Hz, 1H), 6.68 (d, J = 8.0 Hz, 1H), 6.23 (dd, J = 11.2, 2.2 Hz,
1H), 5.50 (br s, 1H), 4.58 (d, J = 23.6 Hz, 1H), 4.17–3.90 (m, 3H),
3.79–3.69 (m, 1H), 1.27 (t, J = 8.0 Hz, 3H), 1.19 (t, J = 8.0 Hz, 3H).
13C NMR (100 MHz, CDCl3) d: 158.9, 144.5, 143.5, 136.3, 131.0,
129.0, 128.0, 126.8, 109.0, 107.0, 96.5, 63.3 (dd, J = 32.5, 7.5 Hz,),
55.2 (d, J = 163.4 Hz), 16.4 (dd, J = 25.6, 5.8 Hz). 31P NMR
(161.7 MHz, CDCl3) d: 22.0. MS: (m/z) 415 (M+).
Synthesis of diethyl (2,2difluorobenzo[d][1,3]dioxol-5-ylamino)
(4-methoxyphenyl) methylphosphonate (4f)
A mixture of p-methoxybenzaldehyde (2f, 1 mmol), 5-amino
2,2-difluoro-1,3-benzodioxole (1, 1 mmol), diethyl phosphite (3,
1 mmol), and BF3ÁSiO2 (5 mol %) were taken in a 10-mL round-bot-
tomed flask containing 1 mL of ([bmim][HCl]) was stirred at room
temperature for 5 min. The progress of the reaction was monitored
by TLC. After completion of the reaction, the mixture was washed
with chloroform and filtered to recover the catalyst. The filtrate
was evaporated, and the crude product was recrystallized from
Diethyl(2,2difluorobenzo[d][1,3]dioxol-5-ylamino)
(4-methylphenyl)methylphosphonate (4e)
Solid, mp 147–149 °C. IR (KBr):
m 3295 (NH), 1228 (P@O), 742
(P–Caliphatic) cmÀ1 1H NMR (400 MHz, CDCl3) d: 7.31 (dd, J = 10.2,
.
iso-propanol, and chloroform (85:15) to afford pure a-aminophos-
phonates in 97% yield. This procedure was applied successfully for
the preparation of other compounds (Table 1).
2.2 Hz, 2H), 7.14 (d, J = 8.0 Hz, 2H), 6.75 (d, J = 8.4 Hz, 1H), 6.34
(d, J = 2.5 Hz, 1H), 6.23 (dd, J = 11.0, 2.5 Hz, 1H), 4.70 (br s, 1H),
4.61 (d, J = 24.2 Hz, 1H), 4.15–4.09 (m, 2H), 3.95–3.87 (m, 1H),
3.66–3.64 (m, 1H), 2.32 (s, 3H), 1.30 (t, J = 6.9 Hz, 3H), 1.11 (t,
J = 7.3 Hz, 3H). 13C NMR (100 MHz, CDCl3) d: 158.9, 144.5, 143.5,
138.0, 136.4, 132.1, 129.5, 127.7, 109.8, 107.8, 96.5, 63.4 (dd,
J = 27.0, 7.1 Hz), 56.3 (d, J = 151.0 Hz), 21.2, 16.4 (dd, J = 27.8,
5.5 Hz). 31P NMR (161.7 MHz, CDCl3) d: 22.2. MS: (m/z) 413 (M+).
Characterization data
Diethyl(2,2difluorobenzo[d][1,3]dioxol-5-ylamino)
(4-bromophenyl)methylphosphonate (4a)
Solid, mp 106–108 °C. IR (KBr):
m 3290 (NH), 1235 (P@O), 740
(P–Caliphatic) cmÀ1 1H NMR (400 MHz, CDCl3) d: 7.22 (dd, J = 11.0,
.
Diethyl(2,2difluorobenzo[d][1,3]dioxol-5-ylamino)
(4-methoxyphenyl)methylphosphonate (4f)
2.2 Hz, 2H), 6.92 (d, J = 8.0 Hz, 2H), 6.75 (d, J = 8.4 Hz, 1H), 6.30
(d, J = 4.5 Hz, 1H), 6.20 (dd, J = 11.0 2.5 Hz, 1H), 4.78 (br s, 1H),
4.58 (d, J = 23.2 Hz, 1H), 4.10–3.90 (m, 2H), 3.85–3.77 (m, 2H),
1.27 (t, J = 6.9 Hz, 3H), 1.14 (t, J = 6.9 Hz, 3H). 13C NMR (100 MHz,
CDCl3) d: 157.9, 144.5, 143.5, 136.5, 133.7, 129.9, 125.8, 119.0,
109.8, 107.0, 96.5, 63.5 (dd, J = 27.2, 5.2 Hz), 56.5 (d, J = 152.0 Hz),
16.4 (dd, J = 24.5, 5.0 Hz). 31P NMR (161.7 MHz, CDCl3) d: 21.2.
MS: (m/z) 477 (M+).
Solid, mp 155–157 °C. IR (KBr):
m 3294 (NH), 1230 (P@O), 762
(P–Caliphatic) cmÀ1 1H NMR (400 MHz, CDCl3) d: 7.35 (dd, J = 10.9,
.
2.5 Hz, 2H), 6.87 (d, J = 8.4 Hz, 2H), 6.76 (d, J = 8.7 Hz, 1H), 6.35
(d, J = 2.2 Hz, 1H), 6.23 (dd, J = 11.0, 2.2 Hz, 1H), 4.90 (br s, 1H),
4.60 (d, J = 23.8 Hz, 1H), 4.15–4.10 (m, 2H), 3.96–3.90 (m, 1H),
3.78 (s, 3H), 3.72–3.60 (m, 1H), 1.30 (t, J = 6.9 Hz, 3H), 1.13 (t,
J = 6.9 Hz, 3H). 13C NMR (100 MHz, CDCl3) d: 159.4, 144.4, 143.6,
136.3, 134.2, 131.6, 129.0, 127.0, 114.1, 109.6, 107.7, 96.5, 63.3
(dd, J = 27.8, 7.1 Hz), 55.5 (d, J = 146.0 Hz), 55.1, 16.3 (dd, J = 24.6,
5.5 Hz). 31P NMR (161.7 MHz, CDCl3) d: 22.2. MS: (m/z) 429 (M+).
Diethyl(2,2difluorobenzo[d][1,3]dioxol-5-ylamino)
(4-chlorophenyl)methylphosphonate (4b)
Solid, mp 99–101 °C. IR (KBr):
m 3295 (NH), 1230 (P@O), 740 (P–
C
aliphatic) cmÀ1 1H NMR (400 MHz, CDCl3) d: 7.22–7.12 (m, 2H),
.
Diethyl(2,2difluorobenzo[d][1,3]dioxol-5-ylamino)
(4-nitrophenyl)methylphosphonate (4g)
6.92–6.84 (m, 2H), 6.70 (d, J = 8.4 Hz, 1H), 6.35 (d, J = 4.0 Hz, 1H),
6.22 (dd, J = 11.0, 2.2 Hz, 1H), 5.90 (br s, 1H), 4.64 (d, J = 23.2 Hz,
1H), 4.10–3.90 (m, 4H), 1.28 (t, J = 6.9 Hz, 3H), 1.14 (t, J = 6.9 Hz,
3H). 13C NMR (100 MHz, CDCl3) d: 158.9, 144.5, 143.6, 136.3,
131.7, 128.9, 126.8, 114.5, 109.6, 107.0, 96.5, 63.3 (dd, J = 30.5,
7.3 Hz), 56.0 (d, J = 154.0 Hz), 16.4 (dd, J = 27.8, 6.2 Hz). 31P NMR
(161.7 MHz, CDCl3) d: 19.1. MS: (m/z) 433 (M+).
Solid, mp 126–128 °C. IR (KBr):
m 3300 (NH), 1230 (P@O), 742
(P–Caliphatic) cmÀ1 1H NMR (400 MHz, CDCl3) d: 8.23 (dd, J = 11.0
.
2.2 Hz, 2H), 7.31 (d, J = 4.0 Hz, 2H), 6.82 (d, J = 8.0 Hz, 1H), 6.29
(d, J = 4.0 Hz, 1H), 6.18 (dd, J = 10.9, 2.2 Hz, 1H), 4.90 (br s, 1H),
4.62 (d, J = 24.0 Hz, 1H), 4.15–3.80 (m, 4H), 1.29 (t, J = 7.2 Hz,
3H), 1.14 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3) d: 158.9,
144.5, 143.5, 136.3, 131.0, 129.0, 128.0, 126.8, 114.7, 109.0,
107.0, 96.5, 63.3 (dd, J = 30.5, 7.5 Hz), 55.2 (d, J = 163.4 Hz), 16.4
(dd, J = 24.5, 5.8 Hz). 31P NMR (161.7 MHz, CDCl3) d: 23.2. MS:
(m/z) 444 (M+).
Diethyl(2,2difluorobenzo[d][1,3]dioxol-5-ylamino)
(4-ethoxyphenyl)methylphosphonate (4c)
Solid, mp 115–117 °C. IR (KBr):
m 3280 (NH), 1235 (P@O), 752
(P–Caliphatic) cmÀ1 1H NMR (400 MHz, CDCl3) d: 7.33 (dd, J = 10.9,
.
2.2 Hz, 2H), 6.86 (d, J = 4.0 Hz, 2H), 6.76 (d, J = 8.0 Hz, 1H), 6.34
(d, J = 4.0 Hz, 1H), 6.23 (dd, J = 10.9, 2.5 Hz, 1H), 5.20 (br, s, 1H),
4.54 (d, J = 16.0 Hz, 1H), 4.16–3.81 (m, 5H), 3.70–3.60 (m, 1H),
1.30 (t, J = 8.2 Hz, 3H), 1.28 (t, J = 8.0 Hz, 3H), 1.10 (t, J = 8.0 Hz,
3H). 13C NMR (100 MHz, CDCl3)). 13C NMR (100 MHz, CDCl3) d:
158.9, 144.5, 143.6, 136.3, 131.7, 128.9, 126.8, 114.5, 109.6,
107.0, 96.5, 63.3 (dd, J = 25.5, 5.5 Hz), 62.4, 56.0 (d, J = 152.0 Hz),
16.4 (dd, J = 23.5, 5.0 Hz,), 14.8. 31P NMR (161.7 MHz, CDCl3) d:
20.2. MS: (m/z) 443 (M+).
Diethyl(2,2difluorobenzo[d][1,3]dioxol-5-ylamino)
(4-Isopropylphenyl)methylphosphonate (4h)
Solid, mp 103–105 °C. IR (KBr):
m 3275 (NH), 1230 (P@O), 745
(P–Caliphatic) cmÀ1 1H NMR (400 MHz, CDCl3) d: 7.35 (dd, J = 10.2,
.
2.2 Hz, 2H), 7.19 (d, J = 8.2 Hz, 2H), 6.75 (d, J = 8.4 Hz, 1H), 6.36
(d, J = 2.5 Hz, 1H), 6.25 (dd, J = 10.9, 2.2 Hz, 1H), 4.99 (br s, 1H),
4.62 (d, J = 24.1 Hz, 1H), 4.15–4.09 (m, 2H), 3.92–3.88 (m, 1H),
3.67–3.61 (m, 1H), 3.00–2.82 (m, 1H), 1.29 (t, J = 8.0 Hz, 3H), 1.21
(dd, J = 19.8, 10.8 Hz, 6H), 1.08 (t, J = 8.0 Hz, 3H).13
C NMR
Diethyl(2,2difluorobenzo[d][1,3]dioxol-5-ylamino)
(4-hydroxyphenyl)methylphosphonate (4d)
(100 MHz, CDCl3) d: 149.5, 144.4, 143.5, 136.2, 132.2, 127.6,
126.6, 109.5, 107.7, 96.3, 63.3 (dd, J = 25.0, 6.3 Hz), 57.0 (d,
J = 152.0 Hz), 33.7, 23.8, 16.3 (dd, J = 36.5, 5.8 Hz). 31P NMR
(161.7 MHz, CDCl3) d: 22.2. MS: (m/z) 441 (M+).
Solid, mp 145–147 °C. IR (KBr):
m 3290 (NH), 1217 (P@O), 740
(P–Caliphatic) cmÀ1 1H NMR (400 MHz, CDCl3) d: 7.50 (s, 1H), 7.18
.